Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jan 14, 2014; 20(2): 414-424
Published online Jan 14, 2014. doi: 10.3748/wjg.v20.i2.414
Published online Jan 14, 2014. doi: 10.3748/wjg.v20.i2.414
Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation
Stephen E Congly, Carla S Coffin, Liver Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, AB T2N 4Z6, Canada
Karen E Doucette, Division of Infectious Diseases, University of Alberta, Edmonton, AB T6G 2R3, Canada
Author contributions: Congly SE, Doucette KE and Coffin CS contributed to this paper equally.
Correspondence to: Carla S Coffin, MD, MSc, FRCPC, Liver Unit, Division of Gastroenterology and Hepatology, University of Calgary, 6D21, Teaching, Research and Wellness Building 3280, Hospital Drive, Calgary, AB T2N 4Z6, Canada. cscoffin@ucalgary.ca
Telephone: +1-403-5925049 Fax: +1-403-5925090
Received: September 24, 2013
Revised: October 22, 2013
Accepted: November 3, 2013
Published online: January 14, 2014
Processing time: 117 Days and 2.4 Hours
Revised: October 22, 2013
Accepted: November 3, 2013
Published online: January 14, 2014
Processing time: 117 Days and 2.4 Hours
Core Tip
Core tip: Liver transplantation is not contraindicated in viral hepatitis patients co-infected with human immunodeficiency virus. Patients should meet standard listing criteria for liver transplantation. Management of these patients should be done through a multidisciplinary management approach including pharmacists and infectious diseases physicians.